Cargando…
Escape from G1 arrest during acute MEK inhibition drives the acquisition of drug resistance
Mutations and gene amplifications that confer drug resistance emerge frequently during chemotherapy, but their mechanism and timing are poorly understood. Here, we investigate BRAF(V600E) amplification events that underlie resistance to the MEK inhibitor selumetinib (AZD6244/ARRY-142886) in COLO205...
Autores principales: | Channathodiyil, Prasanna, May, Kieron, Segonds-Pichon, Anne, Smith, Paul D, Cook, Simon J, Houseley, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575185/ https://www.ncbi.nlm.nih.gov/pubmed/36267209 http://dx.doi.org/10.1093/narcan/zcac032 |
Ejemplares similares
-
NAD(+) bioavailability mediates PARG inhibition-induced replication arrest, intra S-phase checkpoint and apoptosis in glioma stem cells
por: Li, Jianfeng, et al.
Publicado: (2021) -
Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer
por: Wiegmans, Adrian P, et al.
Publicado: (2021) -
Intrinsic ATR signaling shapes DNA end resection and suppresses toxic DNA-PKcs signaling
por: Dibitetto, Diego, et al.
Publicado: (2020) -
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
por: Armstrong, Chris W D, et al.
Publicado: (2020) -
Proteome dynamics analysis identifies functional roles of SDE2 and hypoxia in DNA damage response in prostate cancer cells
por: Luo, Ang, et al.
Publicado: (2020)